Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cassava Sciences stock

Own Cassava Sciences stock in just a few minutes.

Cassava Sciences, Inc is a biotechnology business based in the US. Cassava Sciences shares (SAVA) are listed on the NASDAQ and all prices are listed in US Dollars. Cassava Sciences employs 11 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cassava Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SAVA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cassava Sciences share price

Use our graph to track the performance of SAVA stocks over time.

Cassava Sciences shares at a glance

Information last updated 2021-04-23.
52-week range$1.96 - $117.54
50-day moving average $45.33
200-day moving average $25.53
Wall St. target price$77.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.27

Buy Cassava Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cassava Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cassava Sciences financials

Gross profit TTM $-3,053,000
Return on assets TTM -3.63%
Return on equity TTM -5.69%
Profit margin 0%
Book value $7.45
Market capitalisation $1.5 billion

TTM: trailing 12 months

Shorting Cassava Sciences shares

There are currently 3.4 million Cassava Sciences shares held short by investors – that's known as Cassava Sciences's "short interest". This figure is 5.8% down from 3.6 million last month.

There are a few different ways that this level of interest in shorting Cassava Sciences shares can be evaluated.

Cassava Sciences's "short interest ratio" (SIR)

Cassava Sciences's "short interest ratio" (SIR) is the quantity of Cassava Sciences shares currently shorted divided by the average quantity of Cassava Sciences shares traded daily (recently around 2.5 million). Cassava Sciences's SIR currently stands at 1.38. In other words for every 100,000 Cassava Sciences shares traded daily on the market, roughly 1380 shares are currently held short.

However Cassava Sciences's short interest can also be evaluated against the total number of Cassava Sciences shares, or, against the total number of tradable Cassava Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cassava Sciences's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Cassava Sciences shares in existence, roughly 90 shares are currently held short) or 0.0909% of the tradable shares (for every 100,000 tradable Cassava Sciences shares, roughly 91 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cassava Sciences.

Find out more about how you can short Cassava Sciences stock.

Cassava Sciences share dividends

We're not expecting Cassava Sciences to pay a dividend over the next 12 months.

Have Cassava Sciences's shares ever split?

Cassava Sciences's shares were split on a 1:7 basis on 9 May 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cassava Sciences shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Cassava Sciences shares which in turn could have impacted Cassava Sciences's share price.

Cassava Sciences share price volatility

Over the last 12 months, Cassava Sciences's shares have ranged in value from as little as $1.96 up to $117.54. A popular way to gauge a stock's volatility is its "beta".

SAVA.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cassava Sciences's is 1.1743. This would suggest that Cassava Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Cassava Sciences overview

Cassava Sciences, Inc. , a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site